Financial Snapshot

Revenue
$14.73B
TTM
Gross Margin
5.6%
TTM
Net Earnings
-$331.5M
TTM
Current Assets
$2.656B
Q2 2024
Current Liabilities
$2.479B
Q2 2024
Current Ratio
107.16%
Q2 2024
Total Assets
$2.789B
Q2 2024
Total Liabilities
$3.405B
Q2 2024
Book Value
-$616.1M
Q2 2024
Cash
$495.5M
Q2 2024
P/E
-0.1706
Sep 06, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $14.95B $13.52B $12.43B $8.203B $3.952B $1.786B $959.5M $873.8M
YoY Change 10.59% 8.78% 51.48% 107.57% 121.28% 86.14% 9.81%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $14.95B $13.52B $12.43B $8.203B $3.952B $1.786B $959.5M $873.8M
Cost Of Revenue $14.10B $12.68B $11.80B $7.837B $3.787B $1.682B $868.7M $796.2M
Gross Profit $849.0M $840.0M $621.1M $365.8M $165.2M $104.3M $90.80M $77.60M
Gross Profit Margin 5.68% 6.21% 5.0% 4.46% 4.18% 5.84% 9.46% 8.88%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Selling, General & Admin $796.9M $803.0M $909.4M $619.9M $526.0M $430.0M $291.6M $375.4M
YoY Change -0.76% -11.7% 46.7% 17.85% 22.33% 47.46% -22.32%
% of Gross Profit 93.87% 95.6% 146.42% 169.46% 318.4% 412.27% 321.15% 483.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.068M $5.918M $27.22M $14.00M $11.70M $11.30M $14.80M $12.10M
YoY Change -48.16% -78.26% 94.44% 19.66% 3.54% -23.65% 22.31%
% of Gross Profit 0.36% 0.7% 4.38% 3.83% 7.08% 10.83% 16.3% 15.59%
Operating Expenses $1.199B $1.211B $1.263B $839.2M $658.7M $504.6M $344.8M $441.9M
YoY Change -0.98% -4.14% 50.53% 27.4% 30.54% 46.35% -21.97%
Operating Profit -$350.1M -$371.0M -$642.1M -$473.4M -$493.5M -$400.3M -$254.0M -$364.3M
YoY Change -5.63% -42.22% 35.64% -4.07% 23.28% 57.6% -30.28%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Interest Expense -$10.70M -$13.20M $6.225M $3.000M -$9.100M $6.800M $500.0K $4.200M
YoY Change -18.96% -312.05% 107.5% -132.97% -233.82% 1260.0% -88.1%
% of Operating Profit
Other Income/Expense, Net $7.612M $8.132M $14.89M $3.200M $11.80M $11.50M $4.200M -$3.400M
YoY Change -6.39% -45.39% 365.31% -72.88% 2.61% 173.81% -223.53%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Pretax Income -$353.2M -$376.1M -$621.0M -$467.1M -$501.8M -$382.0M -$249.3M -$363.4M
YoY Change -6.09% -39.44% 32.95% -6.92% 31.36% 53.23% -31.4%
Income Tax $251.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$392.7M -$416.9M -$669.8M -$456.5M -$499.6M -$380.1M -$248.6M -$362.7M
YoY Change -5.8% -37.76% 46.73% -8.63% 31.44% 52.9% -31.46%
Net Earnings / Revenue -2.63% -3.08% -5.39% -5.56% -12.64% -21.28% -25.91% -41.51%
Basic Earnings Per Share -$2.33 -$2.50 -$4.04 -$2.77
Diluted Earnings Per Share -$2.33 -$2.50 -$4.038M -$2.770M -$3.052M -$2.330M -$1.539M -$2.246M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Cash & Short-Term Investments $653.7M $879.5M $843.9M $1.490B $581.3M $1.107B $461.2M $640.3M
YoY Change -25.68% 4.22% -43.35% 156.29% -47.46% 139.92% -27.97%
Cash & Equivalents $603.5M $673.7M $661.4M $1.190B $581.3M $853.7M $167.7M $373.5M
Short-Term Investments $50.14M $205.9M $182.6M $300.2M $0.00 $252.8M $293.5M $266.8M
Other Short-Term Assets $245.8M $325.2M $150.6M $166.7M $139.5M $25.90M $25.50M $21.90M
YoY Change -24.4% 115.9% -9.64% 19.5% 438.61% 1.57% 16.44%
Inventory $1.419B $1.499B $1.142B $776.4M $501.1M $214.2M $148.3M $142.5M
Prepaid Expenses
Receivables $536.8M $488.9M $404.5M $163.1M $65.20M $28.60M $20.40M $28.40M
Other Receivables $77.60M $43.33M $260.5M $276.6M $194.4M $131.8M $75.10M $67.70M
Total Short-Term Assets $2.933B $3.236B $2.802B $2.873B $1.481B $1.507B $730.5M $900.8M
YoY Change -9.35% 15.49% -2.47% 93.92% -1.71% 106.31% -18.91%
Property, Plant & Equipment $138.1M $212.4M $314.1M $142.1M $117.7M $20.30M $17.00M $24.50M
YoY Change -34.95% -32.39% 121.04% 20.73% 479.8% 19.41% -30.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.000M $2.000M $3.000M $100.0K $100.0K $11.10M $11.10M $11.00M
YoY Change 0.0% -33.33% 2900.0% 0.0% -99.1% 0.0% 0.91%
Other Assets $13.31M $20.35M $22.09M $5.100M $3.000M $3.400M
YoY Change -34.59% -7.87% 333.06% 70.0% -11.76%
Total Long-Term Assets $155.7M $238.0M $344.1M $153.8M $128.9M $39.30M $32.90M $40.80M
YoY Change -34.57% -30.84% 123.73% 19.32% 227.99% 19.45% -19.36%
Total Assets $3.089B $3.474B $3.146B $3.027B $1.610B $1.546B $763.4M $941.6M
YoY Change
Accounts Payable $1.589B $1.765B $1.347B $1.073B $444.3M $212.3M $128.1M $98.00M
YoY Change -9.98% 30.99% 25.52% 141.59% 109.28% 65.73% 30.71%
Accrued Expenses $847.7M $781.3M $184.2M $129.1M $94.90M $51.60M $33.70M $41.90M
YoY Change 8.5% 324.23% 42.65% 36.04% 83.91% 53.12% -19.57%
Deferred Revenue
YoY Change
Short-Term Debt $338.1M $179.0M $259.7M $229.3M $95.10M $0.00 $0.00 $0.00
YoY Change 88.88% -31.07% 13.24% 141.11%
Long-Term Debt Due $138.5M $104.2M $46.90M $100.0K $25.60M
YoY Change 32.84% 122.24% 46800.0% -99.61%
Total Short-Term Liabilities $2.774B $2.725B $2.130B $1.630B $773.4M $314.5M $201.2M $172.2M
YoY Change 1.81% 27.94% 30.7% 110.72% 145.91% 56.31% 16.84%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $67.87M $100.5M $167.2M $66.10M $62.90M $8.100M
YoY Change -32.45% -39.89% 152.88% 5.09% 676.54%
Total Long-Term Liabilities $67.87M $100.5M $167.2M $66.10M $62.90M $8.100M $0.00 $0.00
YoY Change -32.45% -39.89% 152.88% 5.09% 676.54%
Total Liabilities $3.672B $3.888B $3.319B $2.669B $833.6M $322.1M $202.6M $174.3M
YoY Change -5.55% 17.15% 24.35% 220.19% 158.8% 58.98% 16.24%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Basic Shares Outstanding 168.6M 166.6M 165.9M 164.8M
Diluted Shares Outstanding 168.6M 166.6M 165.9M 164.8M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $56.556 Million

About 111 Inc

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai and currently employs 1,520 full-time employees. The company went IPO on 2018-09-12. The firm is mainly engaged in the provision of online medical services, drug purchasing and health management services through Internet and information technology. The firm mainly conducts its business in the domestic market.

Industry: Retail-Drug Stores and Proprietary Stores Peers: China Jo-Jo Drugstores Inc